Franchise opportunities compared
G.L.O.M. Global vs Galt Pharmaceuticals
Reviewed figures from each brand's Franchise Disclosure Document (FDD), side by side. Each figure carries its FDD year and page. This is not a ranking or recommendation, and the two FDDs may cover different years and location groups.
Initial investment · Item 7
G.L.O.M. Global
$116,000 – $717,500
2026 FDD · Item 7Galt Pharmaceuticals
$122,350 – $348,700
2026 FDD · Item 7 · PDF p. 21Initial franchise fee · Item 5
G.L.O.M. Global
$58,000
2026 FDD · Item 5 · PDF p. 12Galt Pharmaceuticals
$100,000
2026 FDD · Item 5 · PDF p. 13Royalty · Item 6
G.L.O.M. Global
6% of gross revenues
2026 FDD · Item 6 · PDF p. 13Galt Pharmaceuticals
Not available
Before you compare
- Both sets of figures come from 2026 FDDs.
- G.L.O.M. Global discloses more than one business format, so the investment range spans formats; the full report breaks them out.
- Only Galt Pharmaceuticals has reviewed Item 19 figures here.
Financial commitment
G.L.O.M. Global
Galt PharmaceuticalsG.L.O.M. Global
Galt Pharmaceuticals
G.L.O.M. Global
Galt Pharmaceuticals
G.L.O.M. Global
Galt Pharmaceuticals
G.L.O.M. Global
Galt Pharmaceuticals
System scale & health
G.L.O.M. Global
Galt PharmaceuticalsG.L.O.M. Global
Galt Pharmaceuticals
G.L.O.M. Global
Galt Pharmaceuticals
G.L.O.M. Global
Galt Pharmaceuticals
G.L.O.M. Global
Galt Pharmaceuticals
G.L.O.M. Global
Galt Pharmaceuticals
Financial performance (Item 19), by location group
G.L.O.M. GlobalNot disclosed — no Item 19 financial performance representation
Galt PharmaceuticalsItem 19 groups are shown separately and never combined. Revenue or sales figures are not profit. Net outlet change and turnover are Franopolis calculations from the disclosed counts; turnover is a count-based rate, not a measure of owner earnings.
G.L.O.M. Global vs Galt Pharmaceuticals: common questions
- Which costs less to open, G.L.O.M. Global or Galt Pharmaceuticals?
- G.L.O.M. Global: $116,000 – $717,500 (2026 FDD · Item 7); Galt Pharmaceuticals: $122,350 – $348,700 (2026 FDD · Item 7 · PDF p. 21). These are each franchisor's Item 7 estimated initial investment. The low end of the disclosed estimate is lower for G.L.O.M. Global. At least one range spans several business formats. Estimates are not quotes, and the FDD years may differ.
- Which has more locations, G.L.O.M. Global or Galt Pharmaceuticals?
- G.L.O.M. Global: 1 (2026 FDD · Item 20 · PDF p. 55); Galt Pharmaceuticals: 63 (2026 FDD · Item 20 · PDF p. 48). Total outlets from Item 20. Outlet counts do not indicate territory availability or franchisee results.
- Do G.L.O.M. Global and Galt Pharmaceuticals disclose financial performance (Item 19)?
- G.L.O.M. Global makes no Item 19 financial performance representation; Galt Pharmaceuticals has reviewed Item 19 figures for 4 location groups. Different location groups are not directly comparable, and revenue is not profit.
Answers restate the reviewed figures above. Not a ranking or recommendation.
Keep researching

Full G.L.O.M. Global report
Every reviewed fee, Item 19 group, outlet table and territory disclosure

Full Galt Pharmaceuticals report
Every reviewed fee, Item 19 group, outlet table and territory disclosure



